Resource use and healthcare costs in patients with overactive bladder who initiate treatment with mirabegron or antimuscarinic monotherapy in Catalonia: the MIRACAT study

Autor: Martins de Almeida, R., Mateu Arrom, L., Ortíz Núñez, A., Covernton, P.J.O., Mora Blazquez, A.M.
Zdroj: In Actas Urológicas Españolas (English Edition) April 2022 46(3):184-192
Databáze: ScienceDirect